Inoviq (ASX:IIQ) Operating Cash Flow per Share : A$-0.06 (TTM As of Dec. 2023)

View and export this data going back to 1991. Start your Free Trial

What is Inoviq Operating Cash Flow per Share?

Inoviq's operating cash flow per share for the six months ended in Dec. 2023 was A$-0.02. Inoviq's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.06.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -10.70% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -4.70% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 10.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Inoviq's Operating Cash Flow per Share or its related term are showing as below:

ASX:IIQ' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -218.6 Med: 16 Max: 56.4
Current: -10.7

During the past 13 years, Inoviq's highest 3-Year average Operating Cash Flow per Share Growth Rate was 56.40% per year. The lowest was -218.60% per year. And the median was 16.00% per year.

ASX:IIQ's 3-Year OCF Growth Rate is ranked worse than
69.27% of 179 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.6 vs ASX:IIQ: -10.70

Inoviq Operating Cash Flow per Share Historical Data

The historical data trend for Inoviq's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inoviq Operating Cash Flow per Share Chart

Inoviq Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.04

-0.06

-0.07

-0.08

Inoviq Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.04	-0.03	-0.04	-0.04	-0.02

Competitive Comparison of Inoviq's Operating Cash Flow per Share

For the Diagnostics & Research subindustry, Inoviq's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Inoviq's Price-to-Operating-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Inoviq's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Inoviq's Price-to-Operating-Cash-Flow falls into.

Inoviq Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Inoviq's Operating Cash Flow per Share for the fiscal year that ended in Jun. 2023 is calculated as

Operating Cash Flow per Share (A: Jun. 2023 )	=	Cash Flow from Operations (A: Jun. 2023 )	/	Shares Outstanding (Diluted Average) (A: Jun. 2023 )
	=	-7.025	/	92.019
	=	-0.08

Inoviq's Operating Cash Flow per Share for the quarter that ended in Jun. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )	=	Cash Flow from Operations (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	-1.535	/	92.019
	=	-0.02

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.06

Inoviq Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Inoviq's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Inoviq (ASX:IIQ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Inoviq Ltd (ASX:IIQ) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

23 Normanby Road, Notting Hill, Melbourne, VIC, AUS, 3168

Website

https://www.bard1.com

Inoviq Ltd is engaged in developing and commercializing a portfolio of diagnostic and exosome-based products to improve the diagnosis and treatment of cancer and other diseases. The company has commercialized the hTERT test used as an adjunct to urine cytology testing for bladder cancer and the EXO-NET pan-exosome capture tool for research purposes. Its cancer diagnostic pipeline includes blood tests in development for earlier detection and monitoring of ovarian, breast, prostate, and other cancers.

Inoviq (ASX:IIQ) Headlines

No Headlines